UK markets open in 5 hours 49 minutes
NIKKEI 225
26,809.90 +594.11 (+2.27%) HANG SENG
17,079.51 -143.32 (-0.83%) CRUDE OIL
83.86 +0.23 (+0.28%) GOLD FUTURES
1,708.10 +6.10 (+0.36%) DOW
29,490.89 +765.38 (+2.66%) BTC-GBP
17,276.69 +303.21 (+1.79%)
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 163.36 |
| Open | 164.29 |
| Bid | 162.30 x 900 |
| Ask | 162.95 x 900 |
| Day's range | 161.77 - 164.38 |
| 52-week range | 155.72 - 186.69 |
| Volume | |
| Avg. volume | 6,900,380 |
| Market cap | 429.082B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | 23.76 |
| EPS (TTM) | 6.87 |
| Earnings date | 18 Oct 2022 |
| Forward dividend & yield | 4.52 (2.77%) |
| Ex-dividend date | 22 Aug 2022 |
| 1y target est | 186.89 |
- Zacks
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Johnson & Johnson (JNJ) closed at $163.20 in the latest trading session, marking a -0.1% move from the prior day.
- Business Wire
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
NEW BRUNSWICK, N.J., October 03, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).
- Zacks
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.
© 2022 Yahoo. All rights reserved.
